Skip to main content

Advertisement

Log in

Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to characterize hepatic parenchymal enhancement for normal and diseased liver in dynamic computed tomography (CT) with the dose of contrast medium calculated on the basis of body surface area (BSA).

Materials and methods

The records of 328 consecutive patients who underwent triple-phase contrast-enhanced CT were retrospectively reviewed. The patients were divided into four groups: normal liver (n = 125), chronic hepatitis (CH) (n = 92), Child–Pugh grade A liver cirrhosis (LC-A) (n = 78), and Child–Pugh grade B liver cirrhosis (LC-B) (n = 33). All patients received 22 g I m−2 as contrast material, calculated on the basis of BSA. CT values were measured in the region of interest during the pre-contrast, arterial, and portal phases, and the change in the CT value (ΔHU, where HU is Hounsfield units) compared with pre-contrast images was calculated.

Results

Mean ΔHU for the hepatic parenchyma for the normal liver, CH, LC-A, and LC-B groups during the portal phase was 55.5 ± 11.8 HU, 55.2 ± 12.5 HU, 50.0 ± 13.0 HU, and 43.0 ± 12.7 HU, respectively; generalized estimating equation analysis showed the differences were significant (p < 0.01).

Conclusion

Hepatic parenchymal enhancement during the portal phase decreased as the severity of chronic liver damage increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Foley WD, Mallisee TA, Hohenwalter MD, Wilson CR, Quiroz FA, Taylor AJ. Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol. 2000;175:679–85.

    Article  CAS  PubMed  Google Scholar 

  2. Haider MA, Amitai MM, Rappaport DC, O’Malley ME, Hanbidge AE, Redston M, et al. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology. 2002;225:137–42.

    Article  PubMed  Google Scholar 

  3. Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology. 2004;231:413–20.

    Article  PubMed  Google Scholar 

  4. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology. 1995;195:353–7.

    Article  CAS  PubMed  Google Scholar 

  5. Awai K, Yagyu Y, W R. Optimal injection protocol in hepatic dynamic CT using MDCT. Jpn J Diagnostic Imaging (In Japanese). 2003;23:1017–25.

    Google Scholar 

  6. Furuta A, Ito K, Fujita T, Koike S, Shimizu A, Matsunaga N. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol. 2004;183:157–62.

    Article  PubMed  Google Scholar 

  7. Ho LM, Nelson RC, Delong DM. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT? Radiology. 2007;243:431–7.

    Article  PubMed  Google Scholar 

  8. Bae KT, Seeck BA, Hildebolt CF, Tao C, Zhu F, Kanematsu M, et al. Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity. AJR Am J Roentgenol. 2008;190:777–84.

    Article  PubMed  Google Scholar 

  9. Kondo H, Kanematsu M, Goshima S, Tomita Y, Kim MJ, Moriyama N, et al. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume. Radiology. 2010;254:163–9.

    Article  PubMed  Google Scholar 

  10. Yanaga Y, Awai K, Nakaura T, Utsunomiya D, Oda S, Hirai T, et al. Contrast material injection protocol with the dose adjusted to the body surface area for MDCT aortography. AJR Am J Roentgenol. 2010;194:903–8.

    Article  PubMed  Google Scholar 

  11. Onishi H, Murakami T, Kim T, Hori M, Osuga K, Tatsumi M, et al. Abdominal multi-detector row CT: effectiveness of determining contrast medium dose on basis of body surface area. Eur J Radiol. 2011;80:643–7.

    Article  PubMed  Google Scholar 

  12. Kondo H, Kanematsu M, Goshima S, Watanabe H, Kawada H, Moriyama N, et al. Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight? Eur Radiol. 2013;23:1855–61.

    Article  PubMed  Google Scholar 

  13. Yanaga Y, Awai K, Nakayama Y, Nakaura T, Tamura Y, Hatemura M, Yamashita Y. Pancreas: patient body weight–tailored contrast material injection protocol versus fixed dose protocol at dynamic CT. Radiology. 2007;245:475–82.

    Article  PubMed  Google Scholar 

  14. Yamashita Y, Komohara Y, Takahashi M, Uchida M, Hayabuchi N, Shimizu T, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material––a prospective randomized study. Radiology. 2000;216:718–23.

    Article  CAS  PubMed  Google Scholar 

  15. Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology. 2004;233:682–8.

    Article  PubMed  Google Scholar 

  16. Kanematsu M, Goshima S, Kondo H, Nishibori H, Kato H, Yokoyama R, et al. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 2005;29:195–201.

    Article  PubMed  Google Scholar 

  17. Yanaga Y, Awai K, Nakaura T, Namimoto T, Oda S, Funama Y, et al. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol. 2008;190:1003–9.

    Article  PubMed  Google Scholar 

  18. Partanen KP. Dynamic CT of liver cirrhosis. Invest Radiol. 1984;19:303–8.

    Article  CAS  PubMed  Google Scholar 

  19. Vignaux O, Legmann P, Coste J, Hoeffel C, Bonnin A. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients. AJR Am J Roentgenol. 1999;173:1193–7.

    Article  CAS  PubMed  Google Scholar 

  20. Zissen MH, Wang ZJ, Yee J, Aslam R, Monto A, Yeh BM. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. AJR Am J Roentgenol. 2013;201:1204–10.

    Article  PubMed  Google Scholar 

  21. Ichikawa T, Erturk SM, Araki T. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients’ body-weight-tailored dose of contrast material. Eur J Radiol. 2006;58:165–76.

    Article  PubMed  Google Scholar 

  22. Tsushima Y, Blomley JK, Kusano S, Endo K. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci. 1999;44:1632–8.

    Article  CAS  PubMed  Google Scholar 

  23. Hashimoto K, Murakami T, Dono K, Hori M, Kim T, Kudo M, et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep. 2006;16:677–83.

    PubMed  Google Scholar 

  24. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol. 2001;176:667–73.

    Article  PubMed  Google Scholar 

  25. Marin D, Nelson RC, Scinbera ST, Richard S, Youngblood RS, Yoshizumi TT, et al. Low-tube-voltage, high-tube-current multidetector abdominal CT: improved image quality and decreased radiation dose with adaptive statistical iterative reconstruction algorithm—initial clinical experience. Radiology. 2010;254:145–53.

    Article  PubMed  Google Scholar 

  26. Shindera ST, Diedrichsen L, Muller HC, Rusch O, Marin D, Schmidt B, et al. Iterative reconstruction algorithm for abdominal multidetector CT at different tube voltages: assessment of diagnostic accuracy, image quality, and radiation dose in a phantom study. Radiology. 2011;260:454–62.

    Article  Google Scholar 

  27. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology. 1998;207:647–55.

    Article  CAS  PubMed  Google Scholar 

  28. Foley WD. Dynamic hepatic CT. Radiology. 1989;170:617–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This study was not funded by any entity.

Informed consent

For this retrospective study the requirement for informed consent was waived by the institutional review board.

Ethical standard

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gen Koiwahara.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koiwahara, G., Tsuda, T., Matsuda, M. et al. Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area. Jpn J Radiol 33, 194–200 (2015). https://doi.org/10.1007/s11604-015-0398-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-015-0398-1

Keywords

Navigation